Rapid Dose Therapeutics Corp. filed its Annual on Jan 27, 2023 for the period ending Feb 28, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 CAD | 0.00% | +4.55% | +39.39% |
Mar. 25 | Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding | CI |
Feb. 08 | Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
+39.39% | 20.42M | |
+0.60% | 217M |
- Stock Market
- Equities
- DOSE Stock
- News Rapid Dose Therapeutics Corp.
- Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt